REFERENCES
- Travis SM, Singh PK, Welsh MJ: Antimicrobial peptides and proteins in the innate defense of the airway surface. Curr Opin Immunol. 2001;13:89–95.
- Singh PK, Tack BF, McCray PB Jr, Welsh MJ: Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol. 2000;279:L799-L805.
- Scott MG, Hancock RE: Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit Rev Immunol. 2000;20:407–431.
- Travis SM, Conway BA, Zabner J, Smith JJ, Anderson NN, Singh PK, Greenberg EP, Welsh MJ: Activity of abundant antimicrobials of the human airway. Am J Respir Cell Mol Biol. 1999;20:872–879.
- Ellison RT III, Giehl TJ: Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest. 1991;88:1080–1091.
- Gavrilenko TI, Siurin SA, Lolaeva LT, Savchenko VM: The characteristics of lysozyme and carbenicillin action on the clinico-immunological status of patients with chronic bronchitis. Lik Sprava. 1992;8:42–45.
- Luniakin AA, Bogomaz TA: Lysozyme in the overall treatment of children with an influenza infection and pneumonia. Pediatr Akus Ginekol. 1977;1:11–13.
- Perl M, Chung C-S, Perl U, Lomas-Neira J, de Paepe M, Cioffi WG, Ayala A: Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. Am J Repir Crit Care Med. 2007;176:591–601.
- Hamood AN, Griswold JA, Duhan CM: Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract, and wound infections. 1996;61:425–432.
- Szarka RJ, Wang N, Gordon L, Nation PN, Smith RH. 1997: A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation. J Immunol Methods. 1997;202:49–57.
- Bonapace CR, Friedrich LV, Bosso JA, White RL: Determination of antibiotic effect in an in vitro pharmacodynamic model: comparison with an established animal model of infection. Antimicrob Agents Chemother. 2002;11:3574–3579.
- Omri A, Suntres ZE, Shek PN: Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem Pharmacol. 2002;64:1407–1413.
- Lee M, Kovacs-Nolan J, Yang C, Archbold T, Fan MZ, Mine Y: Hen egg lysozyme attenuates inflammation and modulates local gene expression in a porcine model of dextran sodium sulfate (DSS)-induced colitis. J Agric Food Chem. 2009;57:2233–2240.
- Ogundele MO: A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation. Mediators Inflamm. 1998;7:363–365.
- Holen E, Elsayed S: Characterization of four major allergens of hen egg-white by IEF/SDS-PAGE combined with electrophoretic transfer and IgE-immunoautoradiography. Int Arch Allergy Appl Immunol. 1990;91:136–141.
- Park HS, Nahm DH: New occupational allergen in a pharmaceutical industry: serratial peptidase and lysozyme chloride. Ann Allergy Asthma Immunol. 1997;78:225–229.
- Neu HC, Dreyfus J 3rd, Canfield RE: Effect of human lysozyme on gram-positive and gram-negative bacteria. Antimicrob Agents Chemother. 1968;8:442–444.
- Cole AM, Liao H-I, Stuchlik O, Tilan J, Pohl J, Ganz T: Cationic polypeptides are required for antibacterial activity of human airway fluid. J Immunol. 2002;169:6985–6991.
- Loeffler J, Djurkovic S, Fischetti VA: Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect Immun. 2003;71:6199–6204.
- Cole AM, Thapa DR, Gabayan V, Liao HI, Liu L, Ganz T. Decreased clearance of Pseudomonas aeruginosa from airways of mice deficient in lysozyme M. J Leukoc Biol. 2005;78:1081–1085
- Markart P, Korfhagen TR, Weaver TE, Akinbi HT: Mouse lysozyme M is important in pulmonary host defense against Klebsiella pneumoniae infection. Am J Respir Crit Care Med. 2004;169:454–458.
- Akinbi HT, Epaud R, Bhatt H, Weaver TE: Bacterial killing is enhanced by expression of lysozyme in the lungs of transgenic mice. J Immunol. 2000;165:5760–5766.
- Nash JA, Ballard TN, Weaver TE, Akinbi HT: The peptidoglycan-degrading property of lysozyme is not required for bactericidal activity in vivo. J Immunol. 2006;177;519–526.
- Ibrahim HR, Thomas U, Pellegrini A: A helix-loop-helix peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action. J Biol Chem. 2001;276:43767–43774.